TrialClinical drug investigation2022

Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial.

Yuki Takumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.